The Miami Entrepreneur

Becton Dickinson’s stock bounces as FDA addresses supply issue with blood-culture vials

Read Time:9 Second

Shares of Becton Dickinson & Co. bounced back Wednesday toward their first gain in seven sessions after the Food and Drug Administration addressed supply issues surrounding blood-culture vials.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Wall Street is becoming more skeptical of artificial-intelligence hype helping to power stocks
Next post Core Scientific the first buyer of Block’s 3nm Bitcoin mining ASICs